KANSER HASTALARINDA VENÖZ PORT KATATER KULLANIMI: 5 YILLIK KLİNİK DENEYİMİMİZ

Yıl 2013, Cilt: 17 Sayı: 4, 198 - 205, 01.12.2013

Mehmet Akif Üstüner Baha Zengel Kemal Emre Telciler Ömer Ertürk Hacı Osman Tanrıverdi Enver İlhan

Öz

Port kateter ile uzun süreli intravenöz tedaviler rahatlıkla uygulanabilmektedir. Biz burada son beş yılda kliniğimizde venöz port kateter uygulamalarını sunduk. Kemoterapi uygulaması amacıyla intravenöz port kateter takılan kanser olgularının dosya ve elektronik kayıtları retrospektif olarak incelendi. Toplam 68 hastaya kemoterapi amaçlı port kateter takıldı. Hastaların 28’i kadın %41.2 , 40’ı %58.8 erkek idi. Yaş ortalaması 63.5 idi. Malignite olarak, 37 %54 hastada kolon, 15 %22.1 hastada mide, 8 %11.8 hastada meme, 4 %5.8 hastada pankreas, 2 %2.9 hastada özafagus, 1 %1.5 hastada karaciğer, 1 %1.5 hastada troid kanseri öyküsü vardı. İşlem ameliyathane koşullarında hastalar mönitörize edilerek, lokal anestezi altında yapıldı. Hastaların 64’üne %94.1 subklavyen ven üzerinden kateter takılırken, 4’üne 5.9 femoral ven üzerinden kateter takıldı. Deneyimli kişilerce portun takılması, tespitinin iyi yapılması, uygulama sonrası görüntüleme yöntemleriyle kontrollerinin yapılması ve port kateter bakımının titizlikle uygulanması önem arzetmektedir

Anahtar Kelimeler

Kemoterapi, port kateter, venöz port kateter

USING OF VENOUS PORT CATHETER IN PATIENTS WITH CANCER: A 5-YEAR CLINICAL EXPERIENCE

Öz

The long-term intravenous therapy can easily be applied with port catheter. We present applications of venous port cateter for five years in our clinic. Files and electronic records of cancer patients who were inserted intravenous catheter port were retrospectively analyzed. Port catheter was inserted to 68 patients for chemotheraphy. 28 41.2% of the patients were female,, 40 58.8% of them were male. The mean age was 63.5 years. 37 54% patients had a history of colon ca, 15 22.1% patients had gastric ca, 8 11.8% patients had breast ca, 4 5.8% patients with pancreatic ca, 2 2.9% patients had esophageal ca, 1 1.5% patient had liver ca, one 1.5% patients had thyroid ca. The process were performed in operating conditions under local anestesia and patients were monitored. The catheter inserted through subclavian vein in 64 94.1% patients and through femoral vein in 4 5,9% patients. The installation of port by experienced people, good suturatian, making control of port cateter after application by imaging techniques, the care of catheter port meticulously is important

Anahtar Kelimeler

port catheter, venous port catheter

Kaynakça

• ) Schwarz RE, Groeger JS, Coit DG. Subcutaneously
• venous access devices in cancer patients: a prospective analysis. Cancer 1997; 79: 1635-45.
• central 2) Broviac JW, Cole JJ, Scribner BH. A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet 1973; 136: 602-6. 3) Hickman RO, Buckner CD, Clift RA, et al. A modified right atrial catheter for Access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 1979; 148: 871-5.
• ) Biffi R, De Braud F, Orsi F, et al. A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients. Cancer 2001; 92:1204-12.
• ) Stanislav GV, Fitzgibbons RJ Jr, Bailey RT Jr, et al. Reliability of implantable central venous access devices in patients with cancer. Arch Surg 1987; 122: 1280-3.
• ) Kaygın M.A,Dağ Ö,Güneş M,Şenocak M,Erkut B. Malign hastalarda intravenöz Port
• deneyim.Selçuk Tıp Dergisi 2012;28: 17-21. yıllık
• Klinik 7) Ballarini C, Intra M, Pisani Ceretti A, et al. Complications of subcutaneous infusion port in the general oncology population. Oncology 1999; 56: 97 - 102.
• ) Collier PE, Blocker SH, Graff DM, Doyle P. Cardiac Tamponade from Central Venous Catheters. Am J Surg 1998;176: 212-4.
• ) Sticca RP, Dewing BD, Harris JD. Outcomes of surgical and radiologic placed implantable central venous access ports. Am J Surg 2009; 198: 829-33.
• ) Yıldırım Özdemir N, Abalı H, Öksüzoğlu B, ve ark. It appears to be safe to start chemotherapy on the day of implantation through subcutaneous venous port catheters in inpatient setting. Support Care Cancer 2009; 17: 399-403.
• ) John TC, Jeffrey PL, Todd MMc, Sheryl Living-ston, Joseph AK. A Prospective
• Demonstrating Valved
• Ports Have Fewer Complications And Lower Ove-rall Cost Than Nonvalved Implantable Ports, The American Journal 2004;188:722-7.
• Trial Implantable Of Surgery
• December 12) Krupski G, Froschle GW, Weh FJ, Schlosser GA. Central venous access devices in treatment of patients with malignant tumors: Venous port, central venous catheter and Hickman catheter. Cost-benefit analysis based on a critical review of the literature, personal experiences with 135 port implantations and 1995;66:202-7.
• Chirurgie 13) Groeger JS, Lucas AB, Thaler HAT, et al. Infec-tious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 1993;119:1168-74.
• ) Özer Belin A,Bayar MK.İmplante Edilebilir
• Uygulamalarımızın incelenmesi. Fırat Tıp Dergisi 2011;16: 6-10.
• Kateter 15) Turcotte S, Dube S, Beauchamp G. Peripherally inserted central venous catheters are not superior to central venous catheters in the acute care of surgical patients on the ward. World J Surg 2006; 30: 1605-19.
• ) Cowl CT, Weinstock JV, Al-Jurf A, et al. Complications and cost associated with parenteral nutrition delivered to hospitalized patients through either subclavian
• central catheters. Clin Nutr 2000; 19: 237-43.
• ) Czepizak CA, O’Callaghan JM, Venus B. Evaluation of formulas for optimal positioning of central venous catheters. Chest 1995; 107: 1662.
• ) Di Carlo I, Cordio S, La Greca G, et al. Totally implantable venous access devices
• retrospective study on early and late complications. Arch Surg 2001; 136: 1050-3. surgically
• a 19) Kurul S, Saip P, Aydin T. Totally implantable venous-access ports: local problems and extravasation injury. Lancet Oncol 2002; 3: 684-93.
• ) Gowda MR, Gowda RM, Khan IA, et al. Positional Ventricular Tachycardia from a Fractured Mediport Catheter with Right Ventricular Migration: A Case Report. Angiology2004 ; 55; 557-60. 21) Gullo SM. Implanted Ports, Technologic Advances And Nursing Care Issues, Nursing Clinics Of North America, 1993; 28: 859-71.
• ) Lin CH, Wu HS, Chan DC, et al. The mechanism of failure of totally implantable central venous access system: Analysis of 73 cases with